ReviewFrontiers in pharmacology2022

A novel strategy for bioactive natural products targeting NLRP3 inflammasome in Alzheimer's disease.

Zhiyou Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.